The impact of the COVID-19 pandemic on cancer care

The COVID-19 pandemic has disrupted the spectrum of cancer care, including delaying diagnoses and treatment and halting clinical trials. In response, healthcare systems are rapidly reorganizing cancer services to ensure that patients continue to receive essential care while minimizing exposure to SA...

Full description

Saved in:
Bibliographic Details
Published in:Nature cancer Vol. 1; no. 6; pp. 565 - 567
Main Authors: Richards, Mike, Anderson, Michael, Carter, Paul, Ebert, Benjamin L., Mossialos, Elias
Format: Journal Article
Language:English
Published: England Nature Publishing Group 01.06.2020
Subjects:
Cancer surgery
Cancer therapies
Chemotherapy
Clinical trials
COVID-19
COVID-19 diagnostic tests
Disease transmission
Elective surgery
Endoscopy
Gastroenterology
Hospitals
Infections
Medical screening
Oncology
Pandemics
Patients
Radiation therapy
Severe acute respiratory syndrome coronavirus 2
United Kingdom > UK
England
United States > US
Health services
Oncology
Health policy
ISSN:2662-1347, 2662-1347
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The COVID-19 pandemic has disrupted the spectrum of cancer care, including delaying diagnoses and treatment and halting clinical trials. In response, healthcare systems are rapidly reorganizing cancer services to ensure that patients continue to receive essential care while minimizing exposure to SARS-CoV-2 infection.
Bibliography:SourceType-Scholarly Journals-1
ObjectType-Commentary-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ISSN:2662-1347
2662-1347
DOI:10.1038/s43018-020-0074-y